secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-09-02T21:29:10+00:00
Accession:  0001213900-26-096810
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies announces 1-for-20 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- 1-for-20 reverse split effective 4:30 p.m. ET Sept 7, 2026; trading starts Sept 8, 2026 on Nasdaq under BRTX with new CUSIP 090655705.
- Outstanding shares reduced from 27,622,556 to ~1,381,128; authorized shares cut from 1.5B to 75M.
- Board approved split without stockholder approval under Nevada law; fractional shares rounded up to whole share.
- Split aims to regain compliance with Nasdaq $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026096810/0001213900-26-096810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026096810/ea0304389-8k_biore.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-096810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer